UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

JP Morgan reiterated its Overweight rating on Health Care REIT

and increased its price target from $61 to $62. JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield." Health Care REIT closed at $60.17 on Thursday.